We are live on
!
Find out more
Qube Research & Technologies (QRT) Portfolio holdings
AUM
$89.9B
1-Year Est. Return
20.22%
This Fund
S&P 500
This Quarter
Est. Return
+2.03%
1 Year Est. Return
+20.22%
3 Year Est. Return
+42.42%
5 Year Est. Return
+23.97%
10 Year Est. Return
–
AUM
$23.2B
AUM Growth
+$4.57B
(+24%)
Cap. Flow
+$4.34B
Cap. Flow
% of AUM
18.68%
Top 10 Holdings %
Top 10 Hldgs %
24.47%
Holding
3,215
New
812
Increased
777
Reduced
812
Closed
734
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
FRC
First Republic Bank
FRC
|
+$286M |
| 2 |
Cigna
CI
|
+$183M |
| 3 |
Honeywell
HON
|
+$156M |
| 4 |
ConocoPhillips
COP
|
+$150M |
| 5 |
Abbott
ABT
|
+$120M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$180M |
| 2 |
Vertex Pharmaceuticals
VRTX
|
+$123M |
| 3 |
Alphabet (Google) Class A
GOOGL
|
+$116M |
| 4 |
CME Group
CME
|
+$115M |
| 5 |
Texas Instruments
TXN
|
+$110M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 13.38% |
| 2 | Consumer Discretionary | 11.26% |
| 3 | Healthcare | 10.95% |
| 4 | Financials | 10.85% |
| 5 | Industrials | 9.79% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1401
Asure Software
ASUR
$240M
| $766K | ﹤0.01% |
52,859
+37,587
| +246% | +$444K |
|
1402
Lindsay Corp
LNN
$1.12B
| $762K | ﹤0.01% |
5,041
-3,481
| -41% | -$526K |
|
1403
iShares US Healthcare Providers ETF
IHF
$1.21B
| $761K | ﹤0.01% |
+15,395
| New | +$791K |
|
|
AIF
1404
DELISTED
Apollo Tactical Income Fund Inc.
AIF
| $756K | ﹤0.01% |
62,364
| – | – |
|
1405
Chefs' Warehouse
CHEF
$4.58B
| $754K | ﹤0.01% |
22,131
-50,658
| -70% | -$1.78M |
|
|
DVAX
1406
DELISTED
Dynavax Technologies
DVAX
| $752K | ﹤0.01% |
76,618
-158,995
| -67% | -$1.7M |
|
1407
Vanguard Morningstar Growth ETF
VUG
$218B
| $750K | ﹤0.01% |
18,042
+12,018
| +200% | +$467K |
|
|
PLYA
1408
DELISTED
Playa Hotels & Resorts
PLYA
| $742K | ﹤0.01% |
77,300
-157,245
| -67% | -$1.25M |
|
1409
EnerSys
ENS
$6.74B
| $741K | ﹤0.01% |
+8,528
| New | +$717K |
|
1410
Mativ Holdings
MATV
$472M
| $739K | ﹤0.01% |
+34,400
| New | +$847K |
|
|
AMK
1411
DELISTED
AssetMark Financial Holdings, Inc.
AMK
| $737K | ﹤0.01% |
23,432
+12,678
| +118% | +$355K |
|
|
SCHR
1412
Schwab Intermediately-Term US Treasury ETF
SCHR
$13.3B
| $736K | ﹤0.01% |
29,202
+28,390
| +3,496% | +$708K |
|
|
HFRO
1413
Highland Opportunities and Income Fund
HFRO
$407M
| $732K | ﹤0.01% |
83,319
+20,246
| +32% | +$201K |
|
1414
Wave Life Sciences
WVE
$1.13B
| $730K | ﹤0.01% |
168,624
+93,342
| +124% | +$428K |
|
|
THR
1415
DELISTED
Thermon Group Holdings
THR
| $729K | ﹤0.01% |
+29,265
| New | +$714K |
|
1416
Halozyme
HALO
$9.88B
| $727K | ﹤0.01% |
19,044
-85,672
| -82% | -$4.02M |
|
1417
Aaon
AAON
$7.17B
| $723K | ﹤0.01% |
11,223
+5,284
| +89% | +$291K |
|
1418
Global X Cybersecurity ETF
BUG
$1.26B
| $723K | ﹤0.01% |
30,835
-8,344
| -21% | -$185K |
|
1419
Invesco S&P 500 High Beta ETF
SPHB
$970M
| $722K | ﹤0.01% |
10,317
-8,010
| -44% | -$560K |
|
1420
AbCellera Biologics
ABCL
$1.74B
| $721K | ﹤0.01% |
95,621
-162,896
| -63% | -$1.48M |
|
1421
Empire State Realty Trust
ESRT
$862M
| $721K | ﹤0.01% |
111,045
-72,875
| -40% | -$534K |
|
|
AGS
1422
DELISTED
PlayAGS
AGS
| $720K | ﹤0.01% |
100,687
+68,771
| +215% | +$429K |
|
1423
Thryv Holdings
THRY
$180M
| $717K | ﹤0.01% |
31,111
-64,481
| -67% | -$1.44M |
|
1424
QCR Holdings
QCRH
$1.69B
| $712K | ﹤0.01% |
16,208
+3,963
| +32% | +$198K |
|
1425
Enact Holdings
ACT
$6.63B
| $710K | ﹤0.01% |
+31,043
| New | +$739K |
|
Similar funds
Qube Research & Technologies (QRT)'s Q1 2023 Portfolio in Review
As of Q1 2023, Qube Research & Technologies (QRT) held 3,215 positions worth $23.2B, up 24% from $18.7B the previous quarter. Its ten largest holdings account for 24% of the portfolio.
Qube Research & Technologies (QRT) deployed $4.34B of net new capital in Q1 2023, opening 812 new positions and adding to 777 existing holdings. Its largest new stake was First Republic Bank: 2,786,874 shares worth $39M.
By sector, the portfolio is most concentrated in Technology at 13% of assets, down from 17% a quarter earlier, followed by Consumer Discretionary and Healthcare.
On the sell side, the largest reduction was Apple, an estimated $180M trimmed.
- Qube Research & Technologies (QRT)'s largest Q1 2023 buy was First Republic Bank: 2,786,874 shares worth $39M.
- Qube Research & Technologies (QRT) added most to Cigna in Q1 2023, an estimated $183M increase.
- Qube Research & Technologies (QRT)'s biggest Q1 2023 reduction was Apple, cutting an estimated $180M.
- Qube Research & Technologies (QRT) fully exited Vertex Pharmaceuticals in Q1 2023, selling an estimated $123M.
- Qube Research & Technologies (QRT)'s ten largest holdings make up 24% of its $23.2B portfolio in Q1 2023.
- Qube Research & Technologies (QRT) opened 812 new positions and closed 734 in Q1 2023.
- Qube Research & Technologies (QRT)'s portfolio value rose 24% quarter-over-quarter to $23.2B.
Based on Qube Research & Technologies (QRT)'s 13F filing for Q1 2023, filed 15 May 2023.